Glucotrack Inc (GCTK) Stock Price, Quote & News

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 842 7715

Website: glucotrack.com

Address:

301 Route 17 North, Suite 800, Rutherford, United States

Enzo4u Apr. 6 at 2:31 AM

$GCTK 50 cents this week

0 · Reply

BioTechHealthX Apr. 5 at 5:21 PM

$GCTK GlucoTrack (NASDAQ:GCTK) is developing non-invasive glucose monitoring that could revolutionize diabetes care. If successful, this high-risk biotech could tap into a massive global market—and investors are starting to notice. https://biotechhealthx.com/biotech-news/should-you-buy-glucotrack-gctk-shares-today/

0 · Reply

Willitgoup1982 Apr. 5 at 12:48 PM

$GCTK Paul Goode equals snake. Greedy pieces of shit. Total scam.

0 · Reply

Core366 Apr. 3 at 10:53 PM

$GCTK Always has and always will be , Paul goode is the most inept lying, pos that has ran a publicly traded company with the exception of par chadha...which shorting was exceptional there as well hahahaha

0 · Reply

debbiekatz Apr. 3 at 9:25 PM

$GCTK another microfloat following that same pattern. bottoms out at .62 on 3/31. i post for team next day at .67. comes from same scan as all the others. then goes to .86 area for 28% gain overnight. if you cash out there, then 5K investment makes 1400 overnight. i then post that same stock at .85 yesterday but that wasn't the bottom entry.

1 · Reply

Enzo4u Apr. 3 at 1:59 PM

$GCTK lol why

1 · Reply

FWM23 Apr. 3 at 12:12 PM

$GCTK $2 Monday ?

0 · Reply

FeliciaMath Apr. 2 at 11:41 PM

bought $GCTK at .83

0 · Reply

debbiekatz Apr. 2 at 7:50 PM

$GCTK at .85. microfloat posted for team yesterday at .67 for 27% gain so far.

0 · Reply

FkDisManipulation Apr. 2 at 7:37 PM

$GCTK LMAO @race2zero got wiped out

0 · Reply

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Mar 27, 2026, 8:01 AM EDT - 9 days ago

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Mar 10, 2026, 8:01 AM EDT - 26 days ago

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Jan 29, 2026, 8:01 AM EST - 2 months ago

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Dec 30, 2025, 8:00 AM EST - 3 months ago

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Nov 13, 2025, 4:05 PM EST - 5 months ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 3, 2025, 4:05 PM EST - 5 months ago

Glucotrack, Inc. Encourages Shareholders to Vote

Oct 29, 2025, 4:05 PM EDT - 5 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 28, 2025, 8:00 AM EDT - 5 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

Sep 11, 2025, 8:00 AM EDT - 7 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Aug 14, 2025, 4:05 PM EDT - 8 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 6, 2025, 8:30 AM EDT - 8 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Jul 31, 2025, 8:30 AM EDT - 8 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Glucotrack Announces Repurchase of Series A Warrants

Jun 25, 2025, 10:40 AM EDT - 10 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 8:30 AM EDT - 10 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 12, 2025, 9:05 AM EDT - 10 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 4, 2025, 8:30 AM EDT - 10 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

May 28, 2025, 8:30 AM EDT - 11 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 20, 2025, 8:30 AM EDT - 11 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 14, 2025, 5:10 PM EDT - 11 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 13, 2025, 8:01 AM EDT - 11 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 3, 2025, 8:01 AM EDT - 1 year ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Feb 26, 2025, 8:01 AM EST - 1 year ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 4, 2025, 12:24 PM EST - 1 year ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Jan 29, 2025, 9:00 AM EST - 1 year ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

May 16, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 15, 2024, 4:15 PM EDT - 2 years ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 2, 2024, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Apr 22, 2024, 2:10 PM EDT - 2 years ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 16, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 2, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Enzo4u Apr. 6 at 2:31 AM

$GCTK 50 cents this week

0 · Reply

BioTechHealthX Apr. 5 at 5:21 PM

0 · Reply

Willitgoup1982 Apr. 5 at 12:48 PM

$GCTK Paul Goode equals snake. Greedy pieces of shit. Total scam.

0 · Reply

Core366 Apr. 3 at 10:53 PM

0 · Reply

debbiekatz Apr. 3 at 9:25 PM

1 · Reply

Enzo4u Apr. 3 at 1:59 PM

$GCTK lol why

1 · Reply

FWM23 Apr. 3 at 12:12 PM

$GCTK $2 Monday ?

0 · Reply

FeliciaMath Apr. 2 at 11:41 PM

bought $GCTK at .83

0 · Reply

debbiekatz Apr. 2 at 7:50 PM

$GCTK at .85. microfloat posted for team yesterday at .67 for 27% gain so far.

0 · Reply

FkDisManipulation Apr. 2 at 7:37 PM

$GCTK LMAO @race2zero got wiped out

0 · Reply

JJBurch Apr. 2 at 6:46 PM

$GCTK I would be wary of possible offering here Taking any profits is the way to go for now IMO

1 · Reply

dr_ladybananas Apr. 2 at 3:51 PM

$GCTK short float is at 57% 👀

0 · Reply

FkDisManipulation Apr. 2 at 12:14 PM

$GCTK stinky fk hows that 0.50s coming? 😄 Hoe moe@race2zero spammed and spammed now upset its 0.77 😄 midget can't even see 0.77 BID until i told him just ow.

1 · Reply

FkDisManipulation Apr. 2 at 11:49 AM

$GCTK welfare check on @race2zero 0.77 BID 😄

1 · Reply

BioTechHealthX Apr. 2 at 8:58 AM

$ABEO $CAPR $CTXR $GCTK $REPL Looking for high-upside biotech plays? These small-cap biotech stocks could deliver outsized returns if catalysts align. See which biotech names are trending now. https://biotechhealthx.com/biotech-news/top-10-biotech-stocks-that-could-deliver-1000-returns/

1 · Reply

BioTechHealthX Apr. 2 at 8:27 AM

$ABEO $CAPR $CTXR $GCTK From gene therapy to AI-driven drug discovery, these top 10 biotech stocks are trending now. See which companies are dominating the biotech space today. https://biotechhealthx.com/biotech-news/top-10-biotech-stocks-to-watch-now/

0 · Reply

FkDisManipulation Apr. 1 at 11:22 PM

$GCTK drop from 0.64 to 0.63 🤣

0 · Reply

race2zero Apr. 1 at 11:14 PM

$GCTK thank you, it was a nice drop to .63 from that post.

1 · Reply

FkDisManipulation Apr. 1 at 11:13 PM

$GCTK great call up +15%

0 · Reply

race2zero Apr. 1 at 11:12 PM

$GCTK

0 · Reply

FkDisManipulation Apr. 1 at 11:10 PM

$GCTK smelly stinky fkn midget @race2zero Cant see active BID/ASK 😄 Doesn't know how DCA works 😄 Now doesn't know P&L looks like 😄 The midget fk using RobinHood 🤡 Cant post any screenshots 🤡 LARPing about shorting 🤡

0 · Reply

race2zero Apr. 1 at 11:04 PM

$GCTK sorry, I was taking the rest of the day off. I figured you were gone for the day, probably at the Mercedes dealer or something looking to spend your $100

1 · Reply

Market Cap	870,000.00
Revenue (ttm)	0.00
Net Income (ttm)	-22.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	1.19

Volume	229,500
Avg Vol	1,089,178
Day's Range	N/A - N/A
Shares Out	1.01M
Stochastic %K	23%
Beta	0.61
Analysts	Strong Buy
Price Target	N/A